Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Protocol
  • Published:

Generation of induced pluripotent stem cells from human cord blood cells with only two factors: Oct4 and Sox2

Abstract

Induced pluripotent stem cells (iPSC) provide an invaluable resource for regenerative medicine as they allow the generation of patient-specific progenitors with potential value for cell therapy. However, in many instances, an off-the-shelf approach is desirable, such as for cell therapy of acute conditions or when the patient's somatic cells are altered as a consequence of a chronic disease or aging. Cord blood (CB) stem cells appear ideally suited for this purpose as they are young cells expected to carry minimal somatic mutations and possess the immunological immaturity of newborn cells; additionally, several hundred thousand immunotyped CB units are readily available through a worldwide network of CB banks. Here we present a detailed protocol for the derivation of CB stem cells and how they can be reprogrammed to pluripotency by retroviral transduction with only two factors (OCT4 and SOX2) in 2 weeks and without the need for additional chemical compounds.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Quantitative RT-PCR analysis for pluripotent markers and the two transcription factors c-MYC and KLF4.
Figure 2: Umbilical cord blood collection and separation.
Figure 3: Phoenix Amphotropic 293 cells post transfection.
Figure 4: Morphology of cord blood (CB) CD133+ cells after infection.
Figure 5: Induced pluripotent stem cells (iPSC) from cord blood CD133+ cells.
Figure 6: Characterization of CD133+ and cord blood-induced pluripotent stem (CBiPS) cells.

Similar content being viewed by others

References

  1. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872 (2007).

    Article  CAS  PubMed  Google Scholar 

  2. Aasen, T. et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat. Biotechnol. 26, 1276–1284 (2008).

    Article  CAS  PubMed  Google Scholar 

  3. Kim, J.B. et al. Direct reprogramming of human neural stem cells by OCT4. Nature 461, 649–643 (2009).

    Article  CAS  PubMed  Google Scholar 

  4. Loh, Y.H. et al. Generation of induced pluripotent stem cells from human blood. Blood 113, 5476–5479 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Ye, Z. et al. Human induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood 24, 5473–5480 (2009).

    Article  Google Scholar 

  6. Haase, A. et al. Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell 5, 434–441 (2009).

    Article  CAS  PubMed  Google Scholar 

  7. Eminli, S., Utikal, J., Arnold, K., Jaenisch, R. & Hochedlinger, K. Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression. Stem Cells 26, 2467–2474 (2008).

    Article  CAS  PubMed  Google Scholar 

  8. Kim, J.B. et al. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 454, 646–650 (2008).

    Article  CAS  PubMed  Google Scholar 

  9. Anderlini, P. Effects and safety of granulocyte colony-stimulating factor in healthy volunteers. Curr. Opin. Hematol. 16, 35–40 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Gluckman, E. History of cord blood transplantation. Bone Marrow Transplant. 44, 621–626 (2009).

    Article  CAS  PubMed  Google Scholar 

  11. Gluckman, E. & Rocha, V. Cord blood transplantation: state of the art. Haematologica 94, 451–454 (2009).

    Article  PubMed  PubMed Central  Google Scholar 

  12. Giorgetti, A. et al. Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Cell Stem Cell 5, 353–357 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank Dr. M. Torrabadella, Director of the Banc de Sang i Teixits, Vall d'Hebron for providing cord blood units. We are grateful to Y. Muñoz Santos for expert assistance with cell culture techniques. N.M. was partially supported by the Juan de la Cierva program. This work was partially supported by grants from MICINN, CIBER, the Fondo de Investigaciones Sanitarias (RETIC-RD06/0010/0016), TERCEL, the G. Harold and Leila Y. Mathers Charitable Foundation and Fundación Cellex.

Author information

Authors and Affiliations

Authors

Contributions

A.G.: protocol design, isolation of CB CD133+ cells, generation of iPS cell lines and preparation of manuscript; N.M.: protocol design, isolation of CB CD133+ cells, generation of iPS cell lines and preparation of manuscript; I.R.-P.: characterization of iPS cell lines; C.A.: characterization, selection and provision of CB units; A.V.: preparation of manuscript; and J.C.I.B.: preparation of manuscript.

Corresponding author

Correspondence to Juan Carlos Izpisúa Belmonte.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Giorgetti, A., Montserrat, N., Rodriguez-Piza, I. et al. Generation of induced pluripotent stem cells from human cord blood cells with only two factors: Oct4 and Sox2. Nat Protoc 5, 811–820 (2010). https://doi.org/10.1038/nprot.2010.16

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nprot.2010.16

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research